Find your next paid study

Northern Illinois UniversityNCT07397273

Actual pay is set by the research site.

Phase 3

Evaluating General Anesthesia With Erector Spinae Plane Block vs. Spinal Anesthesia With Erector Spinae Plane Block in Lumbar Decompression Surgeries

The purpose of this study is to determine the optimal anesthetic routine for lumbar decompression surgery. General Anesthesia is the standard of care in spine …

Lumbar Disc HerniationLumbar Disc DiseaseLumbar Radiculopathy

Hospital for Special Surgery, New YorkNCT05444751

~$50 – $1,500

Actual pay is set by the research site.

Disabilities PhysicalFallsFall Prevention+1 more

Adapting, Implementing and Evaluating the Effectiveness of the Home Hazard Removal Program for People With Disabilities

The Home Hazard Removal Program (HARP) is an effective fall prevention intervention program which targets home hazard identification/removal. In this study the…

Washington University School of MedicineNCT07033897

Actual pay is set by the research site.

Non Small Cell Lung CancerPancreatic Ductal Adenocarcinoma

A Phase 1, Open-Label, Dose Escalation and Expansion Study of Mavrostobart (PT199) Administered Alone in Adult Patients With Advanced Solid TuMORs, in CombiNation With a Checkpoint INhibitor TreatinG Wild-type Non-Small Cell Lung Cancer, or in Combination With ChemoTherapy for Metastatic or Advanced PAncreatic Ductal AdenocaRcinoma (MORNINGSTAR)

This is a first-in-human, Phase 1/2, open-label, study designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary effic…

Phanes TherapeuticsNCT05431270

~$150 – $4,200

Actual pay is set by the research site.

Adenocarcinoma of Pancreas

A Phase I Study of a Tropism Modified Conditionally Replicative Adenovirus Vector (RGDCRAdCOX2F) for Endoscopic, Direct-Tumor Delivery in Pancreatic Adenocarcinoma

This is a single center, Phase I dose finding study of a single direct tumor injection of an RGD modified conditionally replicative adenovirus (RGDCRAdcox2F) i…

Masonic Cancer Center, University of MinnesotaNCT06693986

~$150 – $3,000

Actual pay is set by the research site.

Oral CancerHead and Neck Cancer

Impact of Tongue Proactive Strengthening Exercise Program on Speech and Swallowing Outcomes Following Partial/Hemiglossectomy and Reconstruction

This study is being done to determine whether adding a proactive tongue strengthening exercise program using a biofeedback device (the Tongueometer) improves s…

Case Comprehensive Cancer CenterNCT07110142

Actual pay is set by the research site.

SleepCircadian RhythmBlood Pressure+1 more

Sleep and Circadian Contributions to Nighttime Blood Pressure

Broadly, this study (SCN-BP) seeks to examine sleep and circadian factors that contribute to blood pressure levels at night.

University of Alabama at BirminghamNCT05656768

Actual pay is set by the research site.

Phase 2

A Phase II Multicenter Study of Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE)

Background: Many cancers of the testicles and urinary tract are rare diseases; these are diseases that affect less than 200,000 people in the United States. I…

Adenocarcinoma of the BladderSquamous Cell Carcinoma of the BladderTesticular Germ Cell Tumors

National Cancer Institute (NCI)NCT06041503

~$75 – $1,800

Actual pay is set by the research site.

Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer

A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Breast Cancer (MORPHEUS-BREAST CANCER)

This is a Phase Ib/II, open-label, multicenter, randomized umbrella study in participants with breast cancer. The study is designed with the flexibility to ope…

Hoffmann-La RocheNCT04802759

~$150 – $4,500

Actual pay is set by the research site.

Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas

Patients with glial brain tumors have increasingly improved outcomes, with median survival of 5-15 years. However, the treatments, including surgery, radiation…

Low-grade Glioma

University of California, San FranciscoNCT03948490

~$10 – $675

Actual pay is set by the research site.

Phase 2

A Phase 2 Clinical Trial of Nalirifox as Neoadjuvant Treatment for Patients With Borderline Resectable Pancreatic Ductal Adenocarcinoma (Nectar Study)

This phase II trial tests how well liposomal irinotecan, oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) before surgery works in treating patients with …

Borderline Resectable Pancreatic Ductal Adenocarcinoma

Roswell Park Cancer InstituteNCT06821997

~$75 – $3,000

Actual pay is set by the research site.

Cerebral Small Vessel DiseasesCerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and LeukoencephalopathyCerebral Microbleeding+1 more

Retinal Vasoreactivity is a Marker for Cerebral Small Vessel Disease Progression

Cerebral small vessel disease (SVD), present in 80-94% of adults over age 65 years, increases the risk of stroke by 2-fold, and dementia by 2.3-fold. There is …